Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion

Ravi K. Sharma, Joao Lima

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Rapid advancement in multidetector computed tomography (MDCT) technology has allowed rapid acquisition and assessment of coronary anatomy with high spatial resolution establishing itself as a compelling alternative to invasive coronary angiography (ICA). Coronary MDCT angiography (CTA) is the preferred imaging modality in patients with low- to intermediate-risk probability of coronary artery disease (CAD) given its high sensitivity and negative predictive value in assessment of CAD. However, anatomic imaging does not necessarily implicate that the detected stenosis causes downstream myocardial ischemia, a potential therapeutic target using revascularization procedures. Thus, clinical practice guidelines strongly recommend ischemia assessment prior to elective revascularization procedure. The revascularization in patients with concurrent ischemia has been shown to reduce mortality and symptomatic angina. Initial evidence emerges from the Coronary Artery Surgery Study (CASS) registry which reported that patients with multivessel CAD had improved survival with surgical revascularization in the presence of severe ischemia on exercise stress testing, whereas medical therapy was a better approach in patients without significant ischemia. In the nuclear substudy of the COURAGE trial, coronary interventions resulted in a reduction in myocardial ischemia burden compared to optimal medical therapy arm, and the reduction of ischemia was associated with mitigation in anginal symptoms and translated into improved prognosis of the patients. The FAME (Fractional Flow Reserve vs. Angiography for Guiding PCI in Patients with Multivessel Coronary Artery Disease) trial demonstrated that fractional flow reserve (FFR)-guided intervention to determine the functional severity of a coronary stenosis resulted in about one-third reduction in mortality and rate of coronary events (myocardial infarctions) compared to anatomic evaluation of stenosis alone.

Original languageEnglish (US)
Title of host publicationMolecular and Multimodality Imaging in Cardiovascular Disease
PublisherSpringer International Publishing
Pages175-194
Number of pages20
ISBN (Print)9783319196114, 9783319196107
DOIs
StatePublished - Jan 1 2015

Fingerprint

Perfusion
Tomography
Ischemia
Coronary Artery Disease
Multidetector Computed Tomography
Myocardial Ischemia
Pathologic Constriction
Mortality
Coronary Stenosis
Coronary Angiography
Practice Guidelines
Registries
Anatomy
Coronary Vessels
Angiography
Therapeutics
Myocardial Infarction
Exercise
Technology
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sharma, R. K., & Lima, J. (2015). Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion. In Molecular and Multimodality Imaging in Cardiovascular Disease (pp. 175-194). Springer International Publishing. https://doi.org/10.1007/978-3-319-19611-4_9

Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion. / Sharma, Ravi K.; Lima, Joao.

Molecular and Multimodality Imaging in Cardiovascular Disease. Springer International Publishing, 2015. p. 175-194.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sharma, RK & Lima, J 2015, Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion. in Molecular and Multimodality Imaging in Cardiovascular Disease. Springer International Publishing, pp. 175-194. https://doi.org/10.1007/978-3-319-19611-4_9
Sharma RK, Lima J. Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion. In Molecular and Multimodality Imaging in Cardiovascular Disease. Springer International Publishing. 2015. p. 175-194 https://doi.org/10.1007/978-3-319-19611-4_9
Sharma, Ravi K. ; Lima, Joao. / Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion. Molecular and Multimodality Imaging in Cardiovascular Disease. Springer International Publishing, 2015. pp. 175-194
@inbook{d57123a670c2499e86489fd98b9f2160,
title = "Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion",
abstract = "Rapid advancement in multidetector computed tomography (MDCT) technology has allowed rapid acquisition and assessment of coronary anatomy with high spatial resolution establishing itself as a compelling alternative to invasive coronary angiography (ICA). Coronary MDCT angiography (CTA) is the preferred imaging modality in patients with low- to intermediate-risk probability of coronary artery disease (CAD) given its high sensitivity and negative predictive value in assessment of CAD. However, anatomic imaging does not necessarily implicate that the detected stenosis causes downstream myocardial ischemia, a potential therapeutic target using revascularization procedures. Thus, clinical practice guidelines strongly recommend ischemia assessment prior to elective revascularization procedure. The revascularization in patients with concurrent ischemia has been shown to reduce mortality and symptomatic angina. Initial evidence emerges from the Coronary Artery Surgery Study (CASS) registry which reported that patients with multivessel CAD had improved survival with surgical revascularization in the presence of severe ischemia on exercise stress testing, whereas medical therapy was a better approach in patients without significant ischemia. In the nuclear substudy of the COURAGE trial, coronary interventions resulted in a reduction in myocardial ischemia burden compared to optimal medical therapy arm, and the reduction of ischemia was associated with mitigation in anginal symptoms and translated into improved prognosis of the patients. The FAME (Fractional Flow Reserve vs. Angiography for Guiding PCI in Patients with Multivessel Coronary Artery Disease) trial demonstrated that fractional flow reserve (FFR)-guided intervention to determine the functional severity of a coronary stenosis resulted in about one-third reduction in mortality and rate of coronary events (myocardial infarctions) compared to anatomic evaluation of stenosis alone.",
author = "Sharma, {Ravi K.} and Joao Lima",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-19611-4_9",
language = "English (US)",
isbn = "9783319196114",
pages = "175--194",
booktitle = "Molecular and Multimodality Imaging in Cardiovascular Disease",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Computed tomography in the concurrent assessment of coronary morphology and myocardial perfusion

AU - Sharma, Ravi K.

AU - Lima, Joao

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Rapid advancement in multidetector computed tomography (MDCT) technology has allowed rapid acquisition and assessment of coronary anatomy with high spatial resolution establishing itself as a compelling alternative to invasive coronary angiography (ICA). Coronary MDCT angiography (CTA) is the preferred imaging modality in patients with low- to intermediate-risk probability of coronary artery disease (CAD) given its high sensitivity and negative predictive value in assessment of CAD. However, anatomic imaging does not necessarily implicate that the detected stenosis causes downstream myocardial ischemia, a potential therapeutic target using revascularization procedures. Thus, clinical practice guidelines strongly recommend ischemia assessment prior to elective revascularization procedure. The revascularization in patients with concurrent ischemia has been shown to reduce mortality and symptomatic angina. Initial evidence emerges from the Coronary Artery Surgery Study (CASS) registry which reported that patients with multivessel CAD had improved survival with surgical revascularization in the presence of severe ischemia on exercise stress testing, whereas medical therapy was a better approach in patients without significant ischemia. In the nuclear substudy of the COURAGE trial, coronary interventions resulted in a reduction in myocardial ischemia burden compared to optimal medical therapy arm, and the reduction of ischemia was associated with mitigation in anginal symptoms and translated into improved prognosis of the patients. The FAME (Fractional Flow Reserve vs. Angiography for Guiding PCI in Patients with Multivessel Coronary Artery Disease) trial demonstrated that fractional flow reserve (FFR)-guided intervention to determine the functional severity of a coronary stenosis resulted in about one-third reduction in mortality and rate of coronary events (myocardial infarctions) compared to anatomic evaluation of stenosis alone.

AB - Rapid advancement in multidetector computed tomography (MDCT) technology has allowed rapid acquisition and assessment of coronary anatomy with high spatial resolution establishing itself as a compelling alternative to invasive coronary angiography (ICA). Coronary MDCT angiography (CTA) is the preferred imaging modality in patients with low- to intermediate-risk probability of coronary artery disease (CAD) given its high sensitivity and negative predictive value in assessment of CAD. However, anatomic imaging does not necessarily implicate that the detected stenosis causes downstream myocardial ischemia, a potential therapeutic target using revascularization procedures. Thus, clinical practice guidelines strongly recommend ischemia assessment prior to elective revascularization procedure. The revascularization in patients with concurrent ischemia has been shown to reduce mortality and symptomatic angina. Initial evidence emerges from the Coronary Artery Surgery Study (CASS) registry which reported that patients with multivessel CAD had improved survival with surgical revascularization in the presence of severe ischemia on exercise stress testing, whereas medical therapy was a better approach in patients without significant ischemia. In the nuclear substudy of the COURAGE trial, coronary interventions resulted in a reduction in myocardial ischemia burden compared to optimal medical therapy arm, and the reduction of ischemia was associated with mitigation in anginal symptoms and translated into improved prognosis of the patients. The FAME (Fractional Flow Reserve vs. Angiography for Guiding PCI in Patients with Multivessel Coronary Artery Disease) trial demonstrated that fractional flow reserve (FFR)-guided intervention to determine the functional severity of a coronary stenosis resulted in about one-third reduction in mortality and rate of coronary events (myocardial infarctions) compared to anatomic evaluation of stenosis alone.

UR - http://www.scopus.com/inward/record.url?scp=84944191258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944191258&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-19611-4_9

DO - 10.1007/978-3-319-19611-4_9

M3 - Chapter

AN - SCOPUS:84944191258

SN - 9783319196114

SN - 9783319196107

SP - 175

EP - 194

BT - Molecular and Multimodality Imaging in Cardiovascular Disease

PB - Springer International Publishing

ER -